BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 34053904)

  • 1. Accuracy and Clinical Utility of a Tumor Grade- and Stage-based Predictive Model in Localized Upper Tract Urothelial Carcinoma.
    Katayama S; Mori K; Schuettfort VM; Pradere B; Mostafaei H; Quhal F; Rajwa P; Motlagh RS; Laukhtina E; Moschini M; Grossmann NC; Araki M; Teoh JY; Rouprêt M; Margulis V; Enikeev D; Karakiewicz PI; Abufaraj M; Compérat E; Nasu Y; Shariat SF
    Eur Urol Focus; 2022 May; 8(3):761-768. PubMed ID: 34053904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel.
    Seisen T; Peyronnet B; Dominguez-Escrig JL; Bruins HM; Yuan CY; Babjuk M; Böhle A; Burger M; Compérat EM; Cowan NC; Kaasinen E; Palou J; van Rhijn BW; Sylvester RJ; Zigeuner R; Shariat SF; Rouprêt M
    Eur Urol; 2016 Dec; 70(6):1052-1068. PubMed ID: 27477528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pretreatment Risk Stratification for Endoscopic Kidney-sparing Surgery in Upper Tract Urothelial Carcinoma: An International Collaborative Study.
    Foerster B; Abufaraj M; Matin SF; Azizi M; Gupta M; Li WM; Seisen T; Clinton T; Xylinas E; Mir MC; Schweitzer D; Mari A; Kimura S; Bandini M; Mathieu R; Ku JH; Marcq G; Guruli G; Grabbert M; Czech AK; Muilwijk T; Pycha A; D'Andrea D; Petros FG; Spiess PE; Bivalacqua T; Wu WJ; Rouprêt M; Krabbe LM; Hendricksen K; Egawa S; Briganti A; Moschini M; Graffeille V; Kassouf W; Autorino R; Heidenreich A; Chlosta P; Joniau S; Soria F; Pierorazio PM; Shariat SF
    Eur Urol; 2021 Oct; 80(4):507-515. PubMed ID: 34023164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Classification for Upper Tract Urothelial Carcinoma to Better Risk-stratify Patients Eligible for Kidney-sparing Strategies: An International Collaborative Study.
    Marcq G; Foerster B; Abufaraj M; Matin SF; Azizi M; Gupta M; Li WM; Seisen T; Clinton T; Xylinas E; Mir MC; Schweitzer D; Mari A; Kimura S; Bandini M; Mathieu R; Ku JH; Guruli G; Grabbert M; Czech AK; Muilwijk T; Pycha A; D'Andrea D; Petros FG; Spiess PE; Bivalacqua T; Wu WJ; Rouprêt M; Krabbe LM; Hendricksen K; Egawa S; Briganti A; Moschini M; Graffeille V; Autorino R; John P; Heidenreich A; Chlosta P; Joniau S; Soria F; Pierorazio PM; Shariat SF; Kassouf W
    Eur Urol Focus; 2022 Mar; 8(2):491-497. PubMed ID: 33773965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Gontero P; Van Rhijn BWG; Mostafid AH; Palou J; Shariat SF
    Eur Urol; 2018 Jan; 73(1):111-122. PubMed ID: 28867446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update.
    Rouprêt M; Babjuk M; Compérat E; Zigeuner R; Sylvester RJ; Burger M; Cowan NC; Böhle A; Van Rhijn BW; Kaasinen E; Palou J; Shariat SF
    Eur Urol; 2015 Nov; 68(5):868-79. PubMed ID: 26188393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease.
    Rose KM; Murray KS; Labbate C; Woldu S; Linehan J; Jacob J; Kaimakliotis H; Dickstein R; Feldman A; Matin SF; Lotan Y; Humphreys MR; Sexton WJ
    Eur Urol Focus; 2023 Sep; 9(5):807-812. PubMed ID: 37059620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Preoperative Nomogram for Endoscopic Management Decision Making in Upper Urinary Tract Urothelial Carcinoma.
    Nakamoto T; Yoshida T; Katayama S; Ohe C; Kawaura T; Horii S; Ikeda J; Kono Y; Murota T; Kitawaki T; Araki M; Kinoshita H
    Ann Surg Oncol; 2024 Feb; 31(2):1393-1401. PubMed ID: 37925655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update.
    Rouprêt M; Babjuk M; Burger M; Capoun O; Cohen D; Compérat EM; Cowan NC; Dominguez-Escrig JL; Gontero P; Hugh Mostafid A; Palou J; Peyronnet B; Seisen T; Soukup V; Sylvester RJ; Rhijn BWGV; Zigeuner R; Shariat SF
    Eur Urol; 2021 Jan; 79(1):62-79. PubMed ID: 32593530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephroureterectomy vs. segmental ureterectomy of clinically localized, high-grade, urothelial carcinoma of the ureter: Practice patterns and outcomes.
    Piraino JA; Snow ZA; Edwards DC; Hager S; McGreen BH; Diorio GJ
    Urol Oncol; 2020 Nov; 38(11):851.e1-851.e10. PubMed ID: 32859461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Update.
    Rouprêt M; Seisen T; Birtle AJ; Capoun O; Compérat EM; Dominguez-Escrig JL; Gürses Andersson I; Liedberg F; Mariappan P; Hugh Mostafid A; Pradere B; van Rhijn BWG; Shariat SF; Rai BP; Soria F; Soukup V; Wood RG; Xylinas EN; Masson-Lecomte A; Gontero P
    Eur Urol; 2023 Jul; 84(1):49-64. PubMed ID: 36967359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolin-1 Expression in Upper Tract Urothelial Carcinoma.
    D'Andrea D; Moschini M; Foerster B; Abufaraj M; Margulis V; Karam J; Lotan Y; Raman J; Mathieu R; Rouprêt M; Karakiewicz PI; Briganti A; Haitel A; Shariat SF
    Eur Urol Focus; 2019 Jan; 5(1):97-103. PubMed ID: 28753840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to guideline recommendations in the management of upper tract urothelial carcinoma: an analysis of the CROES-UTUC registry.
    Baard J; Shariat SF; Roupret M; Yoshida T; Saita A; Saltirov I; Burgos JR; Celik O; de la Rosette J; Laguna P
    World J Urol; 2022 Nov; 40(11):2755-2763. PubMed ID: 36197507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification for bladder recurrence of upper urinary tract urothelial carcinoma after radical nephroureterectomy.
    Ishioka J; Saito K; Kijima T; Nakanishi Y; Yoshida S; Yokoyama M; Matsuoka Y; Numao N; Koga F; Masuda H; Fujii Y; Sakai Y; Arisawa C; Okuno T; Nagahama K; Kamata S; Sakura M; Yonese J; Morimoto S; Noro A; Tsujii T; Kitahara S; Gotoh S; Higashi Y; Kihara K
    BJU Int; 2015 May; 115(5):705-12. PubMed ID: 24612074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival and Long-term Effects of Kidney-sparing Surgery Versus Radical Nephroureterectomy on Kidney Function in Patients with Upper Urinary Tract Urothelial Carcinoma.
    Hendriks N; Baard J; Beerlage HP; Schout BMA; Doherty KSG; Pelger RCM; Kamphuis GM
    Eur Urol Open Sci; 2022 Jun; 40():104-111. PubMed ID: 35638087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool.
    Xylinas E; Kluth L; Passoni N; Trinh QD; Rieken M; Lee RK; Fajkovic H; Novara G; Margulis V; Raman JD; Lotan Y; Rouprêt M; Aziz A; Fritsche HM; Weizer A; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Walton T; Karakiewicz PI; Montorsi F; Zerbib M; Scherr DS; Shariat SF;
    Eur Urol; 2014 Mar; 65(3):650-8. PubMed ID: 24070577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of secondary bladder cancer following radical nephroureterectomy for upper tract urothelial carcinoma: characteristics, risk factors, and predictive value.
    Lai S; Wu P; Liu S; Seery S; Liu J; He L; Liu M; Zhang Y; Wang JY; Xu T
    BMC Urol; 2022 Dec; 22(1):211. PubMed ID: 36566200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and kidney-sparing treatments for upper tract urothelial carcinoma: state of the art.
    Territo A; Foerster B; Shariat SF; Rouprêt M; Gaya JM; Palou J; Breda A
    Minerva Urol Nefrol; 2018 Jun; 70(3):242-251. PubMed ID: 29392926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma.
    Messer J; Shariat SF; Brien JC; Herman MP; Ng CK; Scherr DS; Scoll B; Uzzo RG; Wille M; Eggener SE; Steinberg G; Terrell JD; Lucas SM; Lotan Y; Boorjian SA; Raman JD
    BJU Int; 2011 Sep; 108(5):701-5. PubMed ID: 21320275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
    Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
    Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.